Analysis of Recently Published Acute Lymphoblastic Leukemia Articles / Studies

Released On
December 7, 2018

Expires On
December 6, 2019

Media Type
Internet

Completion Time
75 minutes

Specialty
Hematology/ Oncology, Primary Care

Scroll to the Bottom of this Information to Begin this Course

This activity is supported by educational funding provided by Amgen and Takeda Oncology.

Credit Available

  • Physicians — maximum of 0.75 AMA PRA Category 1 Credit(s)

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity is intended for hematologist-oncologists and other clinicians interested in the management of patients with acute lymphoblastic leukemia (ALL).

Program Overview

In this CME activity Elias Jabbour, MD, reviews some of the recent clinical developments in advanced acute lymphoblastic leukemia. We invite you to learn more about the current and emerging standards of care, as well as safety and efficacy data from the select clinical trials, in patients with acute lymphoblastic leukemia.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Summarize the latest research developments in the treatment of acute lymphoblastic leukemia
  • Describe how new data and recommendations can impact clinical practices to improve care
  • Incorporate evidence-based research into clinical practice

Faculty

Elias Jabbour, MD

Professor of Medicine
Department of Leukemia
MD Anderson Cancer Center
Houston, Texas

Physician Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physician Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Conflicts of Interest

In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center for Health Sciences policy, the following disclosures have been made:

Elias Jabbour, MD

  • Research Support: Adaptive Biotechnologies, Amgen, Novartis, Pfizer, Takeda

The faculty for this activity has disclosed that there will be no discussion about the use of products for non-FDA approved applications.

Additional content planners

The following have no significant relationship to disclose:

  • Emir Hadzic, PhD (medical writer)
  • Coy Flowers, MD (peer reviewer)

Annenberg Center for Health Sciences

Charles Willis, Director of Continuing Education, consults for Pfizer, Inc; all other staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Disclosure of Unlabeled Use

The faculty for this activity has disclosed that there will be no discussion about the use of products for non-FDA approved applications.

Instructions for Participation and Credit

This activity is an online enduring material. Successful completion is achieved by reading and/or viewing the material(s), reflecting on its implications in your practice, and completing the assessment component.

Hardware and Software Requirements

This site is best viewed with an HTML5 compatible browser, this list includes the versions of Mircrosoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player.

Disclaimer

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient’s unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented. This piece is based on a discussion among the faculty member and was written by a writer from the Annenberg Center. Faculty have final editorial control for the piece.